The quest for optimal interventional strategy in saphenous vein graft interventions-are we there yet?

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 7, 2012, Pages 1118-1119

  Gupta, Saurabh ^a   Cigarroa, Joaquin E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN;

BARE METAL STENT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DEATH; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; GRAFT PATENCY; HEART INFARCTION; HUMAN; NOTE; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; SAPHENOUS VEIN GRAFT; TRANSLUMINAL CORONARY ANGIOPLASTY; VEIN GRAFT DISEASE;

CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; SAPHENOUS VEIN;

EID: 84870943088     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24716     Document Type: Note

References (5)

1. Savage MP, Douglas JS Jr., Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous vein de novo trial investigators. N Engl J Med 1997; 337: 740-747.
2. Mehilli J, Pache J, Abdel-Wahab M, et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): A randomised controlled superiority trial. Lancet 2011; 378: 1071-1078.
3. Brilakis ES, Lichtenwalter C, Abdel-karim AR, et al. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv 2011; 4: 176-182.
4. Vermeersch P, Agostono P, Verheye S, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized delayed RRISC trial. J Am Coll Cardiol 2007; 50: 261-267.
5. Pasceri V, Tarsia G, Niccoli G, et al. Early beneficial effects of drug-eluting stents in vein grafts are reduced during long term follow-up. A case control study. Catheter Cardiovasc Interv 2012; DOI 10.1002/ccd.23468.